Overview of Intrasite Gel

What is Intrasite Gel: Classification and Identity

Property	Description
Active Ingredient	Cross-linked Carboxymethylcellulose (CMC) Polymer
Form	Amorphous Hydrogel (Sterile Topical Gel)
Pharmacological Class	Wound Management Agent / Autolytic Debriding Agent
General Purpose	Creates and maintains a moist wound environment
Origin	Synthetic (Polymer-based), manufactured by Smith & Nephew

Intrasite Gel is a sterile, multi-component amorphous polymer hydrogel dressing intended for topical use in professional wound care settings. It is classified as a hydrogel wound dressing, designated as a medical device rather than a conventional pharmaceutical drug. Functionally, it belongs to the class of Wound Management Agents and Autolytic Debriding Agents. The product is recognized for its ability to effectively manage non-viable tissues, which is essential in wound bed preparation.

Composition and the Hydrogel Form

The foundation of this specific product is its Amorphous Hydrogel form, which is a synthetic preparation stabilized by the presence of Cross-linked Carboxymethylcellulose (CMC) polymer, suspended within an Aqueous Base that includes Purified Water and Propylene Glycol. The cross-linked structure of the CMC polymer is crucial, as it provides the necessary viscosity and mechanical stability for the gel to maintain its physical integrity upon application. The primary role of the gel is to manage moisture at the wound interface, making it suitable for managing dry necrotic wounds where rehydration is necessary.

General Purpose: The Role in Wound Management

The principal objective of using this product is to establish and maintain an optimal, moist wound environment, a key requirement for the body’s natural repair processes. This continuous moisture donation facilitates a natural process known as autolytic debridement, where the body utilizes its own moisture and enzymes to safely and selectively soften and separate non-viable tissues, such as slough or eschar. Intrasite Gel’s general purpose is to provide the necessary conditions to cleanse the wound bed, preparing it for subsequent tissue growth and eventual closure.

What side effects are possible with Intrasite Gel?

Possible Side Effects and Safety Information

Intrasite Gel, a hydrogel wound dressing, is generally considered to have a low potential for causing irritation. The reported adverse events associated with its use are primarily localized and minor in nature. Serious systemic reactions are not typically anticipated from topical application.

Type of Reaction	Common Regulatory Notes	Safety Limitations/Restrictions
Local Skin Reactions	Mild skin irritation; reddening may occur with lengthy or prolonged exposure. Allergic contact dermatitis, including sensitization to components like propylene glycol, is rare but has been reported in susceptible individuals.	Discontinue use if irritation or sensitization develops.
Ocular/Eye Contact	May cause temporary or mild eye irritation, pain, or dryness, particularly if the gel leaks from the dressing and contacts the eye.	Use with caution around the eyes; rinse thoroughly with water if accidental contact occurs.
Systemic Exposure	The gel is not absorbed topically. Ingestion of large amounts is not a normal route of exposure but may potentially cause mild gastrointestinal irritation.	Seek medical attention if ingested or if symptoms of eye irritation persist.
Wound Environment	Prolonged use or improper dressing management, especially on heavily exuding wounds, may lead to maceration of surrounding skin. Infection is a risk for any wound, and the gel should be used alongside appropriate infection treatment if required.	Not ideally suited for wounds with very heavy exudate or deep, narrow tracts where removal may be difficult.

Safety Summary

Official safety documentation highlights the product's stable nature and its classification as neither a dangerous good nor a workplace hazardous substance. The key safety precaution centers on minimizing contact with the eyes and ensuring the dressing is removed safely and completely, particularly from complex or narrow wound beds. While the risk is low, users should be aware of the possibility of mild irritation or, rarely, sensitization.

Overdose and Emergency Response

Intrasite Gel is classified by regulatory bodies as a medical device for external wound management, and is officially documented as not absorbed systemically through the skin. Consequently, the overdose profile is governed by accidental misuse, specifically inadvertent internal exposure or contact with sensitive areas.

Documented manifestations of excessive exposure are localized. For dermal contact, potential skin reddening may occur with lengthy application. Eye contact may cause mild irritation. Accidental ingestion of large amounts may result in gastrointestinal disturbances.

Immediate medical help is required in the event of ingestion. The official protocol mandates contacting a poison control center or physician immediately for instructions, dilution by drinking water, and strictly states Do not induce vomiting. For eye contact, the required supportive measure is to irrigate copiously with clean water for at least 15 minutes and subsequently seek medical attention if symptoms persist. No specific antidote is documented for the gel components.

In all cases of doubt regarding excessive exposure or when symptoms persist, official guidance requires the user to seek medical attention.

Therapeutic Uses of Intrasite Gel

What Intrasite Gel Treats: Main Uses and Benefits

Intrasite Gel is generally applied across therapeutic domains where additional symptomatic support is needed, assisting with the management of symptoms that interfere with daily functioning. It is commonly used when short-term symptomatic assistance is required.

The product is relevant across specific conditions where symptoms may intensify temporarily, including minor burns, superficial lacerations, and chronic conditions like pressure and leg ulcers. The gel plays a role in managing the overall symptom burden in contexts marked by increased discomfort or tension.

For patients experiencing acute or unstable symptom patterns, the gel offers symptomatic relief. This supportive application is often relevant when symptoms intensify and supportive relief is needed, as it may assist with easing symptoms that create noticeable functional strain during these phases.

“This supportive use supports patients during episodes of heightened discomfort.”

Quick Fact: Managing Symptoms Related to Localized Discomfort

Intrasite Gel is primarily relevant for easing symptoms related to physical discomfort and chronic physiological stress in localized areas. It is applied when symptoms create noticeble functional strain.

Regulatory References

NHS Grampian Joint Wound Care Formulary

Eligibility and Restrictions for Use

Who can and cannot use Intrasite Gel?

The population eligibility rules for Intrasite Gel are defined by its classification as a topical medical device, resulting in strict limitations based on hypersensitivity and the site of application, rather than systemic physiological status.

Official Eligibility Constraints

Classification	Rule and Applicability
Absolute Contraindication	The gel must not be used by patients with a known sensitivity or hypersensitivity to Intrasite Gel or any of its constituent ingredients.
Administration Route	The product is strictly for external use only and is prohibited from being ingested.
Conditional Use (Anatomy)	Caution is required when applying the gel in the vicinity of the eyes or in deep wounds with narrow openings (e.g., fistulas) where removal may be difficult.
Lactation Restriction	Use is restricted in the lactating population; application should be avoided on cracked nipples.

Age and Comorbidity Eligibility

Use is established and permitted for general wound management in adults and older adults. There is no formal minimum age restriction, and the product is considered acceptable for use in pediatric patients under professional supervision. Eligibility is not constrained by systemic conditions, such as renal or hepatic impairment, consistent with the product's non-systemically absorbed nature. Patients with common comorbidities, such as diabetes, are generally eligible for use.

What should I know about interactions with other medicines?

Interactions with other medicines and products

Intrasite Gel is classified as a sterile, topical wound management medical device. Its action is physical and localized, facilitating a moist environment without significant systemic absorption of its core components, the Cross-linked Carboxymethylcellulose (CMC) polymer.

Documented Interaction Profile

Official regulatory documentation structures the interaction profile around the absence of systemic risk.

Systemic Drug Interactions: No interactions with orally or systemically administered medicinal products are officially documented. Due to the product's local mode of action, pharmacokinetic mechanisms, such as those involving CYP enzymes or drug transporters, are not relevant or reported in regulatory labeling.
Exposure Modification: There are no documented effects on the clearance or plasma concentration of any co-administered systemic drug, and no substance is documented to alter the gel’s exposure.
Food, Alcohol, and Supplements: The regulatory labeling does not contain any documented interactions with food, alcohol, herbal products, or dietary supplements.

Local Application Constraint

While systemic interactions are not expected, a local constraint exists regarding co-administration at the wound site.

Chemical Incompatibility: Co-administration with strong oxidizing agents is restricted. Substances such as hypochlorite solutions or hydrogen peroxide may chemically degrade the CMC polymer structure of the gel, compromising its physical integrity and performance. This is a local chemical constraint, not a systemic drug interaction.

Mechanism of Action

The mechanism of Intrasite Gel is physical-physiological, operating strictly at the local wound site to engage the autolytic physiological process. It does not exert a pharmacological effect on cellular receptors or enzymes.

The primary mechanistic domain involves the physical interaction of the cross-linked polymer matrix with the wound interface. The CMC hydrogel continually donates moisture to the desiccated non-viable tissue ( eschar and slough), causing it to rehydrate and soften. This sustained hydration is the critical first step in the mechanistic cascade, which is a prerequisite for the subsequent physiological action.

This action's physiological consequence is the creation and maintenance of an optimal aqueous environment that optimizes the operating environment for the host's endogenous proteolytic enzymes (like MMPs) . This optimized environment permits selective lysis and separation of dead tissue from viable tissue, resulting in the separation of non-viable tissue from the wound bed.

Furthermore, the amorphous and viscous nature of the gel establishes a protective barrier that reduces frictional force on exposed tissue during activities like dressing removal, while the polymer provides physical stability contributing to sustained moisture delivery.

Dosage and Administration Information

Intrasite Gel is administered solely via the external topical route as a sterile, amorphous hydrogel, designed for direct application to the wound bed. Its use is based on application thickness and frequency rather than systemic dosing.

The application standard requires the gel to be introduced in a layer of sufficient depth, typically covering the entire wound surface to a minimum of 5 mm. Prior to application, the wound site must be thoroughly prepared by irrigating with sterile saline solution. This preparatory step ensures the optimal environment for the gel to function.

The gel regimen requires the use of a secondary dressing immediately following application. This secondary cover is essential to secure the hydrogel, prevent premature dehydration, and maximize its maintenance of a moist wound environment. The frequency of change is conditional, guided by the amount of wound fluid (exudate); however, the system is typically maintained and changed at least every three days (72 hours) to avoid saturation or breakdown.

Intrasite Gel use is defined as a short-term measure, intended only to assist with the initial stages of wound bed preparation. Application protocols are consistent across adult and older adult populations due to the non-systemic nature of the product, requiring no adjustments for factors like renal or hepatic function. When removing the dressing, the residual gel is gently cleared from the wound bed by rinsing with sterile saline solution.

Recent Clinical Evidence

Research Evidence / Overview of Studies for Intrasite Gel

The available research on Intrasite Gel has focused on its functional role as an amorphous hydrogel, which is primarily to support the creation of conditions required for the body's natural processes. Studies were conducted under specific conditions to understand how the gel was evaluated in various wound types. The findings described group patterns observed during the study periods, and it's important to understand that research does not determine whether an individual will respond similarly.

Evidence for Managing Dry Necrotic Wounds and Autolytic Debridement

Intrasite Gel was studied for its use in wounds that have non-viable tissue—such as slough or dry, hardened tissue known as eschar—that was measured for removal before the wound could proceed to subsequent stages. Researchers conducted clinical trials and observational studies, specifically exploring how symptoms change over time when the gel was evaluated.

The study outcomes examined changes in wound bed composition, particularly measuring the amount of non-viable tissue and the rate of debridement (the natural process of softening and removing that tissue). Studies reported observations related to moisture content at the wound surface. This process is relevant in trials assessing short-term or episodic symptom patterns and research describes physical separation of non-viable tissue. The available evidence describes the product's role in the context of its classification as an autolytic debriding agent.

Evidence for Use in Chronic Conditions: Pressure and Leg Ulcers

Intrasite Gel was evaluated in studies focusing on chronic conditions characterized by fluctuating or episodic manifestations, such as pressure ulcers and leg ulcers. This research explored the use of Intrasite Gel in the context of established chronic conditions.

Studies monitored patient-reported outcomes describing perceived discomfort and pain during dressing changes, as well as outcomes related to physical discomfort. Researchers also examined the gel's role in wound bed preparation. The data show patterns related to wound bed preparation outcomes that were monitored in these patient groups. Findings describe measurements that contributed to understanding symptom patterns during periods where symptoms may vary in intensity.

What is Still Uncertain About the Research for Intrasite Gel

Research limitations frame what is still uncertain about the use of Intrasite Gel. Comparative evidence is lacking against all currently available advanced dressings used for debridement. The evidence quality varies across studies, and some trials have modest sample sizes or limited follow-up durations. The research contributes to the broader evidence landscape but does not offer universal, definitive insight into how the gel performs over many months or years, particularly after the initial treatment phase is complete.

Key Studies & References

Frequently Asked Questions (FAQ)

Common questions about Intrasite Gel (FAQ)

Q: What is the recommended maximum time to leave the dressing in place for necrotic wounds?

Official product information for wounds with dead or sloughy tissue states that the dressing should be changed at least every three days (72 hours). The exact time is conditional and is primarily guided by the amount of fluid (exudate) the wound produces. The dressing system is maintained and changed regularly to support optimal performance.

Q: Is it normal for the wound size to appear to increase in the initial stages of using the gel?

The function of the gel is to support autolytic debridement, which is the body's natural process of selectively separating non-viable tissue (slough or eschar) from the wound bed. This process of cleaning the wound bed may lead to a temporary change in the apparent size or depth of the wound as the non-viable tissue is lifted.

Q: Is there information on using Intrasite Gel for wounds that show signs of infection?

Regulatory safety documentation notes that the risk of infection is present with any wound. The gel is not an antimicrobial product. Official safety documentation notes that the gel is intended to be used alongside appropriate infection treatments if required.

Q: Is it common to experience a slight tingling or discomfort upon initial application?

Product descriptions highlight the gel's gentle action, which is designed to minimize discomfort. While mild skin irritation is noted as a possible local reaction in safety documents, official documentation does not specifically list tingling as an expected initial sensation.

Q: What is the maximum recommended time to keep the gel on a wound that is only granulating?

For clean wounds in the healing stage, known as granulating wounds, the recommended time for leaving the dressing in place is conditional. Official guidance indicates that the frequency of change depends on the clinical condition of the wound and the amount of fluid it is producing, without providing a single specified maximum time limit.

Q: Can Intrasite Gel be used on a minor burn?

Regulatory indications include the use of the gel for the management of superficial wounds, such as minor burns (partial-thickness wounds). The product is used to create a moist wound environment for the healing process.

Q: What is the difference between Intrasite Gel and a hydrocolloid dressing?

Intrasite Gel is classified as an amorphous hydrogel, which primarily works by donating moisture to dry, dead tissue to facilitate its removal. Hydrocolloid dressings, in contrast, contain absorbent material that forms a gel upon contact with moisture and are typically used for wounds producing heavier fluid output.

Q: Does the product information address the use of Intrasite Gel on diabetic foot ulcers?

Yes, official indications confirm that Intrasite Gel can be used for the management of diabetic foot ulcers. Official documentation notes that the management of diabetic foot ulcers should be conducted under the direction and supervision of a qualified healthcare professional.

Q: What is the function of the unique Applipak system dispenser?

The Applipak system is described in product literature as a unique dispenser. Its function is to allow for a simple, directable, and controlled application of the gel, allowing for the application of the necessary amount directly into the wound bed.

Q: Is it safe to use Intrasite Gel on wounds of infants or children?

The product is considered acceptable for use in pediatric patients when applied under the direct supervision of a healthcare professional. Its non-systemic nature means eligibility is generally not constrained by age, but all wound care must be professionally supervised.

Q: What should a patient do if they notice signs of redness or a rash around the wound?

Official safety information advises that if signs of irritation or sensitization (such as redness, inflammation, or a rash) develop, use of the gel should be discontinued. This instruction is a fundamental safety precaution noted in the official documentation.

Q: Is there a limit on how long a patient can continuously use Intrasite Gel?

Regulatory information describes the gel as a short-term measure intended to assist primarily with the initial stages of wound bed preparation, such as debridement. The intended use is focused on the time required to cleanse the wound bed, suggesting application should not be indefinite.

Q: How does the gel contribute to the soothing of painful nerve endings?

Research cited in product literature indicates that the gel's unique composition allows it to conform to the wound contours. By maintaining a continuous, moist environment, the gel may help keep exposed nerve endings bathed in fluid, and this process is described in research as potentially contributing to patient comfort.

Q: Is there any evidence comparing Intrasite Gel to alternative wound dressings, such as alginates or honey?

The summary of available research notes that comparative evidence is lacking against all currently available advanced dressings used for debridement. The existing evidence base contributes to the broader wound care landscape but does not provide extensive, direct comparisons.

Q: What does the research evidence suggest regarding Intrasite Gel for venous leg ulcers?

Studies examined the use of the gel in the context of chronic conditions, including venous leg ulcers. The research monitored outcomes such as patient-reported perceived discomfort and pain during dressing changes, alongside measurements of success related to wound bed preparation.

Q: Can Intrasite Gel be used underneath compression therapy?

Yes, clinical protocols and official formulary guidance often state that the gel may be used under compression therapy when this combination is considered appropriate for the specific wound type being managed.

Q: Is Intrasite Gel suitable for wounds with heavy exudate (very wet)?

Official documentation notes a precaution against using the gel on wounds with very heavy exudate (fluid). Prolonged use on excessively wet wounds may increase the risk of maceration (softening and breakdown) of the healthy skin surrounding the wound.

How should Intrasite Gel be stored and disposed of?

Storage and Disposal: Official Regulatory Information

Scope Item	Official Requirement
Storage Temperature	Store in a cool, dry place, typically below 25 C ( or 77 F).
Prohibited Environments	Must not be frozen; Protect from direct sunlight and excessive heat.
Packaging Rules	Use contents only if the pack is unopened and undamaged to ensure sterility.
Disposal of Unused Gel	Product is for single use only; discard any unused gel immediately after application.
Child Safety	Keep the product and its components away from children. Safely dispose of the protective cap and snap-off tip to avoid choking hazards.
Waste Classification	Dispose of according to local waste regulations. Not classified as a Hazardous Substance for disposal.

Official regulations require the amorphous hydrogel to be stored within a defined temperature range and kept sealed to maintain its sterile, physical structure. The Single Use Only mandate strictly prohibits retaining any unused product. Disposal must adhere to local municipal guidelines for non-hazardous waste.

Intrasite Gel